What emerged during a conversation with BioPharmaDispatch was Michael Oberreiter's striking mix of admiration for Australia’s strengths and concern about its future access to health innovation and the potential broader implications.
Australia has 'all the ingredients' but has to decide what kind of health system it wants
November 26, 2025 BioPharmaBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
Scorecard reveals Australia is still ignoring its deadliest and most costly cancer
November 26, 2025 - - Latest News -
Australian melanoma oncologist awarded inaugural Marie Krogh Prize for Young Women in Science
November 26, 2025 - - Latest News -
Updated asthma guidelines warn against ‘blue puffer only’ treatment as deaths remain stubbornly high
November 26, 2025 - - Latest News -
Australia has 'all the ingredients' but has to decide what kind of health system it wants
November 26, 2025 - - BioPharma -
Report calls for Type 1 diabetes screening with 25,000 unknowingly living with early disease
November 26, 2025 - - Latest News -
New report shows precision approach extends lives but many still missing out
November 25, 2025 - - Latest News -
AusBiotech appoints Anthea Stephenson to lead national industry growth program
November 25, 2025 - - Australian Biotech
